Can you provide the average price target for PHREESIA INC stock?
24 analysts have analysed PHR and the average price target is 28.84 USD. This implies a price increase of 218.36% is expected in the next year compared to the current price of 9.06.
NYSE:PHR • US71944F1066
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PHREESIA INC (PHR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-04-01 | Citizens | Downgrade | Market Outperform -> Market Perform |
| 2026-03-31 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-03-31 | Needham | Maintains | Buy -> Buy |
| 2026-03-31 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2026-03-31 | Truist Securities | Downgrade | Buy -> Hold |
| 2026-03-31 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2026-03-31 | Baird | Downgrade | Outperform -> Neutral |
| 2026-03-31 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-03-31 | Citigroup | Downgrade | Buy -> Neutral |
| 2026-03-26 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-03-24 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-01-23 | DA Davidson | Maintains | Buy -> Buy |
| 2026-01-09 | Wells Fargo | Initiate | Overweight |
| 2026-01-09 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-16 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-10 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-10 | Baird | Maintains | Outperform -> Outperform |
| 2025-12-09 | Needham | Reiterate | Buy -> Buy |
| 2025-12-09 | Barclays | Initiate | Overweight |
| 2025-12-09 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-09 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-09 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-08 | Needham | Reiterate | Buy -> Buy |
| 2025-12-02 | DA Davidson | Maintains | Buy -> Buy |
| 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 356.299M 26.84% | 419.813M 17.83% | 480.591M 14.48% | 533.68M 11.05% | 563.87M 5.66% | 593.1M 5.18% | 724.27M 22.12% | 790.73M 9.18% | 863.05M 9.15% | 941.62M 9.10% | |
| EBITDA YoY % growth | -106.992M 29.28% | -30.211M 71.76% | 24.841M 182.23% | 131.31M 428.60% | 148.62M 13.18% | 167.88M 12.96% | 182.91M 8.95% | 201.6M 10.22% | 222.1M 10.17% | 244.72M 10.18% | |
| EBIT YoY % growth | -136.479M 22.72% | -58.097M 57.43% | -6.612M 88.62% | 38.958M 689.20% | 68.653M 76.22% | 74.387M 8.35% | 86.961M 16.90% | 101.4M 16.60% | 117.46M 15.84% | 135.34M 15.22% | |
| Operating Margin | -38.30% | -13.84% | -1.38% | 7.30% | 12.18% | 12.54% | 12.01% | 12.82% | 13.61% | 14.37% | |
| EPS YoY % growth | -1.18 47.09% | -1.02 13.56% | 0.06 105.88% | 0.61 915.30% | 0.97 59.60% | 0.67 -31.44% | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.08 219.76% | 0.11 976.46% | 0.15 52.26% | 0.14 614.37% | 0.25 196.69% | 0.28 158.73% | 0.32 112.77% | 0.31 117.73% |
| Revenue Q2Q % growth | 132.58M 14.36% | 132.24M 12.78% | 131.49M 9.27% | 130.65M 2.82% | 150.1M 13.21% | 149.53M 13.07% | 153.77M 16.94% | 153.95M 17.83% |
| EBITDA Q2Q % growth | 30.504M 749.46% | 31.475M 146.28% | 34.092M 33.67% | 35.266M 36.18% | 35.226M 15.48% | 37.141M 18.00% | 40.646M 19.22% | 40.679M 15.35% |
| EBIT Q2Q % growth | 8.082M 345.88% | 11.297M 849.64% | 13.448M 259.67% | 14.439M 359.83% | 10.593M 31.07% | 12.575M 11.31% | 14.557M 8.25% | 19.663M 36.18% |
All data in USD
24 analysts have analysed PHR and the average price target is 28.84 USD. This implies a price increase of 218.36% is expected in the next year compared to the current price of 9.06.
PHREESIA INC (PHR) will report earnings on 2026-05-26.
The consensus EPS estimate for the next earnings of PHREESIA INC (PHR) is 0.08 USD and the consensus revenue estimate is 132.58M USD.
The number of analysts covering PHREESIA INC (PHR) is 24.